C4 Therapeutics's market cap is currently $158.71M. The company's EPS TTM is $-0.37; its P/E ratio is ―; C4 Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
